Financial focus

Supplement manufacturing giant Pharmavite acquires FoodState

Supplement manufacturing giant Pharmavite acquires FoodState

By Hank Schultz

Dietary supplement manufacturing giant Pharmavite LLC has made a big move into natural channel supplements with its acquisition of whole food supplement manufacturer FoodState Inc. Pharmavite acquired the company from the private equity firm 2X Consumer...

BASF sells Norwegian omega-3 business to US firm

BASF sells Norwegian omega-3 business to US firm

By Shane STARLING

BASF has sold its Norwegian, “natural fish oils, medium-concentrated omega-3s, and customised bottled fish oil” plant to Pennsylvania firm Marine Ingredients for an undisclosed sum as the German ingredients and chemicals giant switches its focus to high-end...

Euromonitor, Naturex on vitamins and supplement growth in Mexico

Special edition: LATAM

Obesity prevention key to Mexican vitamin & supplement market growth

By Maggie Hennessy

Sales of vitamins and dietary supplements grew 9% in 2013 to reach Mx$15.7 billion ($1.2 billion) as increased visibility over the country’s main diseases have consumers thinking more about prevention, according to a report from Euromonitor International. 

Burcon: Q1 value still mostly from outside operations

Burcon: Q1 value still mostly from outside operations

By Maggie Hennessy

Functional plant protein supplier Burcon reported total revenues of just $25,000 in the fiscal first quarter of 2015, derived mainly from deferred royalty payments from ADM for Clarisoy sales. 

Red Queen theory argues that despite inducing greater and more speedy responses from rivals, the most active and aggressive firms are the best performers.

Red Queen Rules: Understanding nutra space acquisition and evolution

By Dr Matthew Jones

By analysing the long-lasting commitments and acquisition activity of major companies Dr Matthew Jones at CPL Business Consultants uses the Red Queen theory to develop an understanding of their corporate mind-set and appetite for acquisitions and partnerships...

Herbalife misses profit estimates, share price plunges

Herbalife misses profit estimates, share price plunges

By Hank Schultz

Herbalife's share price dropped sharply yesterday as the company reported second quarter earnings that missed analysts’ estimates.  Shares dropped 11% almost immediately on the news and declined further in early trading today, with a share price...

Supplement market headwinds beset GNC as earnings decline in Q2

Supplement market headwinds beset GNC as earnings decline in Q2

By Hank Schultz

The past year has been a tough one for the sales of dietary supplements, and retailing giant GNC is not immune to those trends.  In the company’s second quarter 2014 earnings GNC reported declines in both overall revenue and net income year-over-year.

Jamieson Labs sold to US private equity firm

Jamieson Labs sold to US private equity firm

By Hank Schultz

Jamieson’s Laboratories, Ltd, Canada’s leading dietary supplement manufacturer, has entered into an agreement to sell the company to CCMP Capitol Advisors for a reported $300 million.

Federal budget bill boosts FDA funding, according AHPA analysis

Federal budget bill boosts FDA funding, according AHPA analysis

By Hank Schultz

The new omnibus appropriations bill that surprisingly sailed through Congress recently contains significant budget increases for the Food and Drug administration. Whether those increases will match FDA’s expanded responsibilities under the Food Safety...

Herbalife granted 25th direct selling license in China

Herbalife granted 25th direct selling license in China

By Hank Schultz

Direct selling giant Herbalife has passed a milestone by receiving its 25th direct selling license in China.  Direct selling activities are closely regulated in China, making the receiving of licenses a key metric for growth in the country.

Nestlé buys Louisiana depression food firm

Nestlé buys Louisiana depression food firm

By Shane STARLING

Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

Evolva pays €550,000 for Fluxome resveratrol business

Evolva pays €550,000 for Fluxome resveratrol business

By Shane Starling

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.

Reckitt Benckiser bids $1.4bn for Schiff

Reckitt Benckiser-Schiff: Another giant jumps into nutra space

By Shane STARLING

UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second biggest dietary supplements firm, Schiff Nutrition...

DSM buys Fortitech for €495m; “We are done for awhile”

DSM buys Fortitech for €495m; “We are done for awhile”

By Shane Starling

Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient blending giant, Fortitech (€212m/$270m annual turnover).

Q3 wrap: Nutrition stars for DSM and Naturex

Q3 wrap: Nutrition stars for DSM and Naturex

By Shane Starling

Royal DSM saw Q3 sales slip 7% to €2.3bn across all divisions with polymer intermediates performing worst, but as has been the case in recent quarters, the Dutch firm’s nutrition cluster held firm with 1% organic growth in difficult economic times.

Follow us

Products

View more

Webinars